Skip to content

Comparative study of nasal septum retainer and trans-septal suturing in patients undergoing septoplasty: a randomized controlled trial

Comparative study of nasal septum retainer and trans-septal suturing in patients undergoing septoplasty: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073690
Enrollment
Unknown
Registered
2023-07-19
Start date
2023-07-20
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deviated nasal septum

Interventions

Septum retainer group:Following the septoplasty, the septum retainer is placed into the patient's nasal cavity by the operator.
Trans-septal suturing :Following the septoplasty, the surgeon performed a trans-septal suture on the nasal septum mucosa with four stitches.

Sponsors

Shanghai East Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Participants of any gender, aged between 18 and 65 years old; 2. Participants who voluntarily agree to participate in this clinical trial and provide signed informed consent; 3. Participants who have been diagnosed with a deviated nasal septum; 4. Participants who have been evaluated by an otolaryngologist and deemed suitable for surgery.

Exclusion criteria

Exclusion criteria: 1. Concurrent presence of nasal vestibulitis, chronic sinusitis, or malignant tumors in the nasal cavity; 2. Abnormal coagulation functions or other hematological disorders; 3. History of nasal septal surgery; 4. Pregnancy; 5. Inability to tolerate general anesthesia. 6. Poorly controlled chronic diseases; 7. Presence of psychological or psychiatric disorders; 8. Any other factors identified by the investigators that may render the participant unsuitable for inclusion or may interfere with their participation in the study.

Design outcomes

Primary

MeasureTime frame
closure time;

Secondary

MeasureTime frame
SNOT-22 score;VAS score;Complications;

Countries

China

Contacts

Public ContactWeihua Wang

Shanghai East Hospital

whwangcn@tongji.edu.cn+86 189 1830 0635

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026